My Next Health builds health applications that provide insights into the prevention and treatment of
chronic diseases using a novel approach to functional genomics. These applications allow consumers to
self-manage those insights based on their own genetic predispositions and can help inform their
healthcare providers on interventions. My Next Health was created when functional genomics company
The DNA Company joined with digital therapeutics platform My Pain Sensei in May 2020.
As My Next Health, the company will focus on using precision medicine and digital therapeutics to
develop genomics-based health management applications that offer patients genetic insights tailored to
their unique biology. The merger provides My Next Health with a Class 1 Medical Device Establishment
License from Health Canada for applications related to chronic pain and COVID-19.-19.